当前位置: X-MOL 学术Xenobiotica › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Pharmacokinetic evaluation of oxaliplatin combined with S-1 (SOX) chemotherapy in a rat model of colorectal cancer with acute kidney injury: predictive renal biomarkers for dose optimisation
Xenobiotica ( IF 1.8 ) Pub Date : 2023-12-19 , DOI: 10.1080/00498254.2023.2283736
Takumi Tanaka 1 , Shinji Kobuchi 1 , Yukako Ito 1 , Toshiyuki Sakaeda 1
Affiliation  

Dose adjustment based on renal function is essential in S-1, which contains the 5‑fluorouracil prodrug tegafur, and platinum-based agent oxaliplatin (SOX) combination chemotherapy for colorectal c...

中文翻译:

奥沙利铂联合 S-1 (SOX) 化疗在结直肠癌伴急性肾损伤大鼠模型中的药代动力学评价:用于剂量优化的预测性肾脏生物标志物

S-1 含有 5-氟尿嘧啶前药替加氟和铂类药物奥沙利铂 (SOX) 联合化疗,用于结直肠癌,根据肾功能调整剂量至关重要。
更新日期:2023-12-24
down
wechat
bug